Article | September 8, 2020

Impact Of COVID-19 On Clinical Trial Operations: How Leaders Are Changing Their Transformation Agendas

By Blake Adams, VP of Marketing, Florence

EHR Adoption

COVID-19 radically disrupted clinical trial operations and forced an acceleration of the transformation agendas leaders had in place pre-crisis. While clinical operations leaders understood the importance of harnessing technology to streamline processes and remotely connect clinical study stakeholders, the transformation timeline was gradual over the next five-plus years.

However coping measures to mitigate COVID disruptions will have a measurable impact on the industry and its shift to more substantial technology infrastructure.

While the acceleration of pre-crisis transformation agendas in clinical trial operations will be measurable, it will not leap to a 10+ year horizon. Instead, it will settle into a more manageable four-year future state: 2021 will now resemble the predictions for 2025.

This blog takes a deeper dive into these changes and how it will affect the industry.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: